Center for Drug Discovery conducts multidisciplinary research aimed at the discovery of new therapeutic medications
Recent Publications
February 1, 2024
December 18, 2017
Nature 547, 468–471 (27 July 2017) The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC)1. […]
December 18, 2017
Cell – Volume 167, Issue 3, p750–762.e14, 20 October 2016 Cannabinoid receptor 1 (CB1) is the principal target of Δ9-tetrahydrocannabinol (THC), a psychoactive chemical from Cannabis […]
About Center for Drug Discovery
The CDD was founded in 2003 and is directed by Alexandros Makriyannis, the Behrakis Chair in Pharmaceutical Biotechnology. The CDD is directed to:
- Develop novel methodologies to improve drug discovery
- Discover new medications to satisfy important medical needs
- Train students and post-doctoral fellows in the art and science of drug discovery
- Collaborate intensively with the biotechnology and pharmaceutical industries as well as leading clinical centers
